| Long non-coding RNAs in cancer: implications for personalized therapy M Vitiello, A Tuccoli, L Poliseno Cellular oncology 38, 17-28, 2015 | 110 | 2015 |
| Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells M Vitiello, A Tuccoli, R D’Aurizio, S Sarti, L Giannecchini, S Lubrano, ... Oncotarget 8 (15), 25395, 2017 | 73 | 2017 |
| Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma M Vitiello, M Evangelista, N Di Lascio, C Kusmic, A Massa, F Orso, S Sarti, ... Oncogene 38 (19), 3756-3762, 2019 | 35 | 2019 |
| The landscape of BRAF transcript and protein variants in human cancer A Marranci, Z Jiang, M Vitiello, E Guzzolino, L Comelli, S Sarti, S Lubrano, ... Molecular Cancer 16, 1-25, 2017 | 31 | 2017 |
| MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response I Barravecchia, S Mariotti, A Pucci, F Scebba, C De Cesari, S Bicciato, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1865 (9 …, 2019 | 20 | 2019 |
| Biological role of miR-204 and miR-211 in melanoma M Vitiello, R D’Aurizio, L Poliseno Oncoscience 5 (7-8), 248, 2018 | 17 | 2018 |
| PTENP1 is a ceRNA for PTEN: it’s CRISPR clear M Vitiello, M Evangelista, Y Zhang, L Salmena, PP Pandolfi, L Poliseno Journal of Hematology & Oncology 13, 1-5, 2020 | 16 | 2020 |
| Identification of BRAF 3'UTR isoforms in melanoma A Marranci, A Tuccoli, M Vitiello, E Mercoledi, S Sarti, S Lubrano, ... The Journal of investigative dermatology 135 (6), 1694-1697, 2015 | 14 | 2015 |
| Kidins220/ARMS interacts with Pdzrn3, a protein containing multiple binding domains M Andreazzoli, G Gestri, E Landi, B D’Orsi, M Barilari, A Iervolino, ... Biochimie 94 (9), 2054-2057, 2012 | 13 | 2012 |
| Proteomics pipeline for phosphoenrichment and its application on a human melanoma cell model F Finamore, N Ucciferri, G Signore, A Cecchettini, E Ceccherini, M Vitiello, ... Talanta 220, 121381, 2020 | 10 | 2020 |
| Kidins220/ARMS is dynamically expressed during Xenopus laevis development S Marracci, M Giannini, M Vitiello, M Andreazzoli, L Dente Int J Dev Biol 57 (9-10), 787-792, 2013 | 9 | 2013 |
| GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma M Scatolini, A Patel, E Grosso, M Mello‐Grand, P Ostano, R Coppo, ... British Journal of Dermatology 186 (1), 117-128, 2022 | 7 | 2022 |
| An immunocompetent environment unravels the proto-oncogenic role of miR-22 ML Centomo, M Vitiello, L Poliseno, PP Pandolfi Cancers 14 (24), 6255, 2022 | 5 | 2022 |
| Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system A Corrado, R Aceto, R Silvestri, I Dell'Anno, B Ricci, S Miglietta, C Romei, ... Thyroid 31 (7), 1056-1066, 2021 | 5 | 2021 |
| PARP1 negatively regulates MAPK signaling by impairing BRAF-X1 translation A Marranci, A Prantera, S Masotti, R De Paolo, C Baldanzi, MS Podda, ... Journal of Hematology & Oncology 16 (1), 33, 2023 | 4 | 2023 |
| Methods for the identification of PTEN-targeting microRNAs A Tuccoli, M Vitiello, A Marranci, F Russo, L Poliseno PTEN: Methods and Protocols, 111-138, 2016 | 4 | 2016 |
| In vivo silencing/overexpression of lncRNAs by CRISPR/Cas system M Vitiello, L Poliseno, PP Pandolfi Long Non-Coding RNAs in Cancer, 205-220, 2021 | 3 | 2021 |
| A network of MicroRNAs and mRNAs involved in melanosome maturation and trafficking defines the lower response of pigmentable melanoma cells to targeted therapy M Vitiello, A Mercatanti, MS Podda, C Baldanzi, A Prantera, S Sarti, ... Cancers 15 (3), 894, 2023 | 2 | 2023 |
| Analysis of lymph node volume by ultra-high-frequency ultrasound imaging in the Braf/Pten genetically engineered mouse model of melanoma M Vitiello, C Kusmic, F Faita, L Poliseno JoVE (Journal of Visualized Experiments), e62527, 2021 | 2 | 2021 |
| Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology A Corrado, R Aceto, S Miglietta, R Silvestri, I Dell’Anno, I Lepori, B Ricci, ... 3 Biotech 14 (2), 45, 2024 | 1 | 2024 |
